MMJ BioScience Partner Receives Cannabis Pharma Manufacturing License From Health Canada For FDA Study

RESTON, Va., March 11, 2018 /PRNewswire-PRWeb/ – MMJ International Holdings, the premier medical cannabis research company, advancing the science of medical marijuana legally through patient clinical research and the operation of medical cannabis healthcare businesses, announced that its affiliate MMJ Bioscience is developing cannabinoid medicines based on proprietary scientific formulations for treatment of patients suffering from Multiple Sclerosis and Huntington’s disease.

MMJ partners is the only company to have secured a License in Canada to Produce Cannabis for Medical Purposes which will enable the extraction of our MMJ Active Pharmaceutical Ingredients from the cannabis plant and to manufacture gelcap medications and supply pharma-grade medicines for its FDA approved studies. These facilities are licensed by Health Canada, inspected by US FDA and are fully GMP compliant.

MMJ BioScience LLC is a U.S. based biopharmaceutical company engaged in the development of cannabinoid-based drugs under U.S. Food and Drug Administration (FDA) protocols that

... read more at:


Leave a Reply